WebThis study analyzed data from three large, randomized bisphosphonate trials. Subtrochanteric or diaphyseal femur fractures were very rare, even among women who had been treated with bisphosphonates... WebJan 23, 2024 · Atypical femoral fractures (AFFs) are rare events associated with increased duration of bisphosphonate exposure. Recommended management of AFFs include cessation of bisphosphonates and imaging of the contralateral femur.
What are Bisphosphonates? - News-Medical.net
WebMay 31, 2024 · Bisphosphonate (BP) is used for its prevention and treatment of osteoporosis. Atypical femoral fracture (AFF) has been recently recognized as a complication associated with BP use. AFF is considered to be a form of stress fracture; localized periosteal thickening of the lateral cortex is often present at the fracture site. WebDec 1, 2024 · Atypical femur fracture (AFF) is an uncommon complication in patients on long-term bisphosphonate (BP) therapy. It was first described in 2005 and has since been widely discussed in the literature because it is associated with high morbidity in patients receiving treatment for osteoporosis. tdk intiba
Absence of femoral cortical thickening in long-term …
WebApr 13, 2024 · Femoral localized reaction (localized periosteal thickening of the lateral cortex, beaking) is reported to precede atypical femoral fractures (AFFs) and to develop in 8–10% of patients with autoimmune diseases taking BPs and glucocorticoids. WebConclusions Bisphosphonate use may be associated with atypical subtrochanteric fractures, but the case is unproven and requires further research. Were the case to be proven, the risk–benefit ratio still remains favourable for use of bisphosphonates to prevent fractures. Keywords Atypical.Bisphosphonate.Femur.Low trauma.Osteoporosis ... WebAug 5, 2024 · Moreover, regular femoral X-rays are essential to screen for the localized femoral reaction (beaking) that precedes AFF . When beaking is evident, bisphosphonate discontinuation with a switch to vitamin D supplementation or teriparatide therapy might improve the prognosis or at least prevent exacerbation of the condition [ 20 ]. tdk iam-20680